|
1 |
Fibrinolytic and Thrombolytic Parameters in Patients with Deep Vein Thrombosis Treated by Low Molecular Weight and Standard Heparin
Enthalten in Seminars in thrombosis and hemostasis Bd. 15, 2008, Nr. 04: 435-439
|
|
|
|
2 |
Efficacy of a Synthetic Pentasaccharide, a Pure Factor Xa Inhibitor, as an Antithrombotic Agent – A Pilot Study in the Setting of Coronary Angioplasty
Enthalten in Thrombosis and haemostasis Bd. 81, 1999, Nr. 02: 214-220
|
|
|
|
3 |
Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial
Enthalten in Thrombosis and haemostasis Bd. 77, 1997, Nr. 05: 0834-0838
|
|
|
|
4 |
Factors influencing the variations of ejection fraction during exercise in chronic aortic regurgitation
Enthalten in European journal of nuclear medicine and molecular imaging Bd. 13, Nr. 8, date:11.1987: 419-424
|
|
|
|
5 |
Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
Enthalten in Trials Bd. 7, 21.12.2006, Nr. 1, date:12.2006: 1-11
|
|
Administration
